SMi proudly presents the return of the 7th annual Pharmaceutical Microbiology conference to Holiday Inn Kensington Forum, London on 22 – 23 January 2018
LONDOM, UNITED KINGDOM, September 21, 2017 /EINPresswire.com/ — The microbiology market has significantly grown in recent years as the demand from end user industries increases. Recent years have seen extraordinary advances in the technologies available to study microbial biology. The development of new techniques to probe individual cells and molecules is a major driver of scientific advance. This topic will be addressed throughout the 'Sterility Assurance and Rapid Microbial Methods' section of day two. The presentations will aim to cover and showcase several new advanced techniques that have been successfully applied to microbiology and have diverse applications which we know will attract a broad audience across all disciplines.
The 2018 meeting of minds will once again provide the perfect forum to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and rapidly evolving market and will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology.
The 2018 agenda will focus on the complex challenge that the field is facing such as endotoxin testing, best practices in cleaning & disinfection, contamination control case studies and rapid microbial-detection methods.
To find out more about the event please visit: www.pharma-microbiology.com/EIN
2018 Expert speaker line-up:
• Patrick Nieuwenhuizen, Manager Quality Control, Genzyme Ireland Ltd
• Ingo Spreitzer, Deputy head, Section Microbial safety, Paul Ehrlich Institut
• Francesco Boschi, Site Quality Assurance Manager, Pfizer
• Benoit Ramond, Senior Microbiology Expert, Sanofi
• Felix Montero Julian, Scientific Director, BioMérieux
• Shahram Lavasani, CEO, ImmuneBiotech AB
• Ian Symonds, Head, Aseptic Intelligence and Strategy, GSK
• Jeremy Webb, Professor of Microbiology, Principal Investigator Biofilms and Microbial Communities University Of Southampton
• Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
• Ruth Daniels, Senior Scientist, Microbiology Expert, Janssen Pharmaceuticals
• Jan-Oliver Karo, Assessor, Paul Ehrlich Institut
New Topics of discussion will include:
• How the development of mycoplasma testing could potentially revolutionise quality control
• Fungal and bacterial spores and spore contamination control
• Mycoplasma control and safety concepts in the 21st century – A regulator's view on ATMPs
• Bio contamination control – is it time to change our approach?
• General sterility and aseptic technique
• Environmental monitoring – managing excursions and out of trends
• Biofilms – what are they and why do they pose such an issue within drug development and delivery
The event will also feature two post-conference workshops, Addressing Objectionable Organisms – What, Why, Who, How? and Rapid Microbial Methods (Led by Sanofi and Battellle Memorial Institute).
Join the room full of industry experts to discuss: microbial contamination in aseptic manufacturing environments; risk assessments in fungal spore and bacterial spore excursions; optimising rapid microbial detection methods; tackling the current challenge of biofilms and much more.
2018 Sponsors: BioMérieux, Charles River, Lonza, NCIMB Ltd & Roche
For media enquiries please contact Kyra Williams on +44 20 7827 6012 or email email@example.com
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: firstname.lastname@example.org
For delegate and group bookings contact Kieran Ronaldson on +44 (0) 20 7827 6744 or email: email@example.com
7th annual Pharmaceutical Microbiology
22nd – 23rd January 2018
Holiday Inn Kensington Forum, London UK
Organisers: SMi Group
Tel: +44 (0) 207 827 6012
SMi Group Ltd
+44 (0)20 7827 6012
email us here
Source: EIN Presswire